We have an excellent peer review process that supports our strategic priorities while remaining responsive to new opportunities. Our Scientific Executive Board oversees all committees and they all adhere to our thorough code of practice (PDF, 96KB) and Terms of Reference (PDF, 387KB) and the CR-UK Conflicts of Interest Policy (PDF, 290KB).
Our committees and relevant schemes
- Clinical Careers Committee – Oversees our funding of clinical academic careers in cancer research.
- Clinical Research Committee – Reviews Biomarker Project Grants, Feasibility Study Project Grants, Phase III Clinical Trial Grants and Prospective Sample Collections Project Grants.
- Drug Discovery Committee – Oversees our drug discovery infrastructure and reviews Biotherapeutic Drug Discovery Programme Awards, Biotherapeutic Drug Discovery Project Awards and Small Molecule Drug Discovery Project Awards.
- Early Diagnosis Advisory Group – Reviews early diagnosis policy research project awards.
- Grand Challenge Advisory Panel – Sets the challenges and reviews applications for our Grand Challenge Awards.
- New Agents Committee – Reviews Drug Development Projects, NAC Trial Grants, NAC Trial Endorsements and NAC Preclinical Grants.
- New Investigator Committee – Oversees our funding to support independent researchers from the start of their careers in cancer research.
- Pioneer Awards Committee – Responsible for reviewing, selecting and approving the funding of applications for the Pioneer Award.
- Population Research Committee – Reviews Population Research Committee (PRC) Programme Grants, Population Research Committee (PRC) Project Grants, Population Research Postdoctoral Fellowship and the CRUK/Bupa Foundation Cancer Prevention Fellowship.
- Science Committee – Reviews Science Committee Programme Awards, Programme Foundation Awards, Cancer Immunology Project Awards and Multidisciplinary Project Awards.
- Tobacco Advisory Group – Reviews tobacco policy research project awards.
Our funding committees are overseen by the Scientific Executive Board, who are responsible for developing and implementing our scientific strategy.
In exceptional circumstances, the board also consider approaches for funding that do not easily fall within the scope of our existing funding committees and relevant schemes.
This may be due to a number of factors, such as the cost of research exceeds the funding limits available to a committee, the scope of research spans the remit of multiple funding committees, an initiative involves a consortia-based approach, or there is a need to recruit international leadership in a key research area.
Search all funding calls
Find your perfect scheme or grant and take the next step in your research career.